image
Healthcare - Medical - Devices - NASDAQ - US
$ 0.6502
-1.5 %
$ 50.6 M
Market Cap
-1.16
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one HYPR stock under the worst case scenario is HIDDEN Compared to the current market price of 0.65 USD, Hyperfine, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one HYPR stock under the base case scenario is HIDDEN Compared to the current market price of 0.65 USD, Hyperfine, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one HYPR stock under the best case scenario is HIDDEN Compared to the current market price of 0.65 USD, Hyperfine, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart HYPR

image
$1.8$1.8$1.6$1.6$1.4$1.4$1.2$1.2$1.0$1.0$0.8$0.8$0.6$0.615 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
12.9 M REVENUE
16.84%
-43.2 M OPERATING INCOME
10.17%
-40.7 M NET INCOME
7.95%
-38.8 M OPERATING CASH FLOW
7.28%
-383 K INVESTING CASH FLOW
52.36%
1.02 M FINANCING CASH FLOW
485.63%
2.32 M REVENUE
-36.29%
-10.8 M OPERATING INCOME
1.81%
-10.4 M NET INCOME
-0.62%
-8.36 M OPERATING CASH FLOW
1.88%
-8 K INVESTING CASH FLOW
94.97%
54 K FINANCING CASH FLOW
-93.65%
Balance Sheet Hyperfine, Inc.
image
Current Assets 53.7 M
Cash & Short-Term Investments 37.6 M
Receivables 8.3 M
Other Current Assets 7.76 M
Non-Current Assets 5.19 M
Long-Term Investments 0
PP&E 3.12 M
Other Non-Current Assets 2.07 M
63.91 %14.10 %13.17 %5.30 %3.51 %Total Assets$58.9m
Current Liabilities 8.73 M
Accounts Payable 1.61 M
Short-Term Debt 0
Other Current Liabilities 7.12 M
Non-Current Liabilities 1.13 M
Long-Term Debt 0
Other Non-Current Liabilities 1.13 M
16.30 %72.22 %11.48 %Total Liabilities$9.9m
EFFICIENCY
Earnings Waterfall Hyperfine, Inc.
image
Revenue 12.9 M
Cost Of Revenue 7 M
Gross Profit 5.89 M
Operating Expenses 49.1 M
Operating Income -43.2 M
Other Expenses -2.5 M
Net Income -40.7 M
20m20m10m10m00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)13m(7m)6m(49m)(43m)3m(41m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
45.70% GROSS MARGIN
45.70%
-335.33% OPERATING MARGIN
-335.33%
-315.90% NET MARGIN
-315.90%
-83.03% ROE
-83.03%
-69.13% ROA
-69.13%
-86.15% ROIC
-86.15%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Hyperfine, Inc.
image
00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)(70m)(70m)(80m)(80m)202020202021202120222022202320232024202420252025
Net Income -40.7 M
Depreciation & Amortization 1.01 M
Capital Expenditures -383 K
Stock-Based Compensation 4.36 M
Change in Working Capital -3.62 M
Others -1.6 M
Free Cash Flow -39.2 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Hyperfine, Inc.
image
HYPR has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 12
6. Ownership
Insider Ownership Hyperfine, Inc.
image
Sold
0-3 MONTHS
7.38 K USD 1
3-6 MONTHS
2.38 K USD 1
6-9 MONTHS
2.88 K USD 1
9-12 MONTHS
2.42 K USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
HYPR Stock Jumps on NVIDIA Partnership to Advance AI Neuroimaging Hyperfine partners with NVIDIA to integrate advanced AI into its Swoop MRI system, aiming to transform neuroimaging with faster and more accessible brain scan solutions. zacks.com - 1 month ago
Hyperfine, Inc. (HYPR) Q4 2024 Earnings Call Transcript Hyperfine, Inc. (NASDAQ:HYPR ) Q4 2024 Results Conference Call March 17, 2025 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group Maria Sainz - President and Chief Executive Officer Brett Hale - Chief Administrative Officer and Chief Financial Officer Conference Call Participants Brandon Carney - B. Riley Young Li - Jefferies Operator Ladies and gentlemen, thank you for standing by. seekingalpha.com - 1 month ago
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results GUILFORD, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced fourth quarter and full year 2024 financial results and provided a business update. globenewswire.com - 1 month ago
Hyperfine, Nvidia Partner To Make Brain MRIs More Affordable Hyperfine, Inc. HYPR shares are surging on Monday. benzinga.com - 1 month ago
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025 GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. will report financial results for the fourth quarter and full year 2024 on Monday, March 17, 2025. businesswire.com - 1 month ago
Hyperfine Announces $6.0 Million Registered Direct Offering GUILFORD, Conn.--(BUSINESS WIRE)---- $HYPR--Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine” or the “Company”) today announced it has entered into a definitive agreement with investors for the purchase and sale of 4,511,278 shares of the Company's Class A common stock and warrants to purchase up to 4,511,278 shares of Class A common stock. Each share of Class A common stock and accompanying warrant were sold together at a combined offering price of $1.33 in a registered direct offering. The warrants have an e. businesswire.com - 2 months ago
Hyperfine Reports on Growing Evidence for the Use of Swoop® System Images in Stroke Diagnosis Presented at the 2025 International Stroke Conference GUILFORD, Conn.--(BUSINESS WIRE)---- $HYPR #aipowered--Hyperfine reports on new data at ISC 2025 showcasing the growing potential for using images from AI-powered portable MRI for stroke diagnosis. businesswire.com - 2 months ago
Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces global expansion of commercial operations into Turkey, Israel and Saudi Arabia to support Swoop® system expansion plans. businesswire.com - 4 months ago
Hyperfine Announces Strategic Leadership Additions to Drive Growth in Key Business Verticals GUILFORD, Conn.--(BUSINESS WIRE)--Strategic appointments position Hyperfine to drive the adoption of the Swoop® system in hospital settings and expand into the office setting. businesswire.com - 4 months ago
Hyperfine, Inc. (HYPR) Q3 2024 Earnings Call Transcript Hyperfine, Inc. (NASDAQ:HYPR ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group Maria Sainz - President and CEO Brett Hale - Chief Administrative Officer and CFO Conference Call Participants Yuan Zhi - B. Riley Operator Good afternoon. seekingalpha.com - 5 months ago
Hyperfine, Inc. (HYPR) Reports Q3 Loss, Tops Revenue Estimates Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.15 per share a year ago. zacks.com - 5 months ago
Hyperfine, Inc. Reports Third Quarter 2024 Financial Results GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced third quarter 2024 financial results and provided a business update. globenewswire.com - 5 months ago
8. Profile Summary

Hyperfine, Inc. HYPR

image
COUNTRY US
INDUSTRY Medical - Devices
MARKET CAP $ 50.6 M
Dividend Yield 0.00%
Description Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.
Contact 351 New Whitfield Street, Guilford, CT, 06437 https://hyperfine.io
IPO Date Jan. 28, 2021
Employees 111
Officers Ms. Maria Sainz Chief Executive Officer, President & Director Mr. R. Scott Huennekens CPA, M.B.A. Executive Chairman Dr. Jonathan M. Rothberg Ph.D. Founder & Vice Chairman Dr. Thomas Teisseyre Ph.D. Chief Operating Officer Rafael O'Halloran Vice President of Technology Mr. Edmond Knopp M.D. Chief Medical Officer Dave Castiglioni Chief Commercial Officer Mr. Brett Hale Chief Administrative Officer, Chief Financial Officer, Chief Compliance Officer, Treasurer & Corporate Secretary